PBMs profit off expensive niche meds

Pharmacy benefits managers are building lucrative side businesses in specialty drugs, becoming in some cases the sole distributors for certain niche medications. Critics say distributing these drugs--whose prices are rising much faster than other meds'--could conflict with the PBMs' primary mission of keeping overall drug prices down for health insurers.

- read the story in the New York Times

Related Articles:
Specialty-drug spending spawns protest. Specialty drug report
Can specialty drugs turn pharma tide? Drug report
Specialty drugs emerge as key price driver. Drug report